342 related articles for article (PubMed ID: 30787463)
1. Genome-wide association study of germline variants and breast cancer-specific mortality.
Escala-Garcia M; Guo Q; Dörk T; Canisius S; Keeman R; Dennis J; Beesley J; Lecarpentier J; Bolla MK; Wang Q; Abraham J; Andrulis IL; Anton-Culver H; Arndt V; Auer PL; Beckmann MW; Behrens S; Benitez J; Bermisheva M; Bernstein L; Blomqvist C; Boeckx B; Bojesen SE; Bonanni B; Børresen-Dale AL; Brauch H; Brenner H; Brentnall A; Brinton L; Broberg P; Brock IW; Brucker SY; Burwinkel B; Caldas C; Caldés T; Campa D; Canzian F; Carracedo A; Carter BD; Castelao JE; Chang-Claude J; Chanock SJ; Chenevix-Trench G; Cheng TD; Chin SF; Clarke CL; ; Cordina-Duverger E; Couch FJ; Cox DG; Cox A; Cross SS; Czene K; Daly MB; Devilee P; Dunn JA; Dunning AM; Durcan L; Dwek M; Earl HM; Ekici AB; Eliassen AH; Ellberg C; Engel C; Eriksson M; Evans DG; Figueroa J; Flesch-Janys D; Flyger H; Gabrielson M; Gago-Dominguez M; Galle E; Gapstur SM; García-Closas M; García-Sáenz JA; Gaudet MM; George A; Georgoulias V; Giles GG; Glendon G; Goldgar DE; González-Neira A; Alnæs GIG; Grip M; Guénel P; Haeberle L; Hahnen E; Haiman CA; Håkansson N; Hall P; Hamann U; Hankinson S; Harkness EF; Harrington PA; Hart SN; Hartikainen JM; Hein A; Hillemanns P; Hiller L; Holleczek B; Hollestelle A; Hooning MJ; Hoover RN; Hopper JL; Howell A; Huang G; Humphreys K; Hunter DJ; Janni W; John EM; Jones ME; Jukkola-Vuorinen A; Jung A; Kaaks R; Kabisch M; Kaczmarek K; Kerin MJ; Khan S; Khusnutdinova E; Kiiski JI; Kitahara CM; Knight JA; Ko YD; Koppert LB; Kosma VM; Kraft P; Kristensen VN; Krüger U; Kühl T; Lambrechts D; Le Marchand L; Lee E; Lejbkowicz F; Li L; Lindblom A; Lindström S; Linet M; Lissowska J; Lo WY; Loibl S; Lubiński J; Lux MP; MacInnis RJ; Maierthaler M; Maishman T; Makalic E; Mannermaa A; Manoochehri M; Manoukian S; Margolin S; Martinez ME; Mavroudis D; McLean C; Meindl A; Middha P; Miller N; Milne RL; Moreno F; Mulligan AM; Mulot C; Nassir R; Neuhausen SL; Newman WT; Nielsen SF; Nordestgaard BG; Norman A; Olsson H; Orr N; Pankratz VS; Park-Simon TW; Perez JIA; Pérez-Barrios C; Peterlongo P; Petridis C; Pinchev M; Prajzendanc K; Prentice R; Presneau N; Prokofieva D; Pylkäs K; Rack B; Radice P; Ramachandran D; Rennert G; Rennert HS; Rhenius V; Romero A; Roylance R; Saloustros E; Sawyer EJ; Schmidt DF; Schmutzler RK; Schneeweiss A; Schoemaker MJ; Schumacher F; Schwentner L; Scott RJ; Scott C; Seynaeve C; Shah M; Simard J; Smeets A; Sohn C; Southey MC; Swerdlow AJ; Talhouk A; Tamimi RM; Tapper WJ; Teixeira MR; Tengström M; Terry MB; Thöne K; Tollenaar RAEM; Tomlinson I; Torres D; Truong T; Turman C; Turnbull C; Ulmer HU; Untch M; Vachon C; van Asperen CJ; van den Ouweland AMW; van Veen EM; Wendt C; Whittemore AS; Willett W; Winqvist R; Wolk A; Yang XR; Zhang Y; Easton DF; Fasching PA; Nevanlinna H; Eccles DM; Pharoah PDP; Schmidt MK
Br J Cancer; 2019 Mar; 120(6):647-657. PubMed ID: 30787463
[TBL] [Abstract][Full Text] [Related]
2. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.
Morra A; Escala-Garcia M; Beesley J; Keeman R; Canisius S; Ahearn TU; Andrulis IL; Anton-Culver H; Arndt V; Auer PL; Augustinsson A; Beane Freeman LE; Becher H; Beckmann MW; Behrens S; Bojesen SE; Bolla MK; Brenner H; Brüning T; Buys SS; Caan B; Campa D; Canzian F; Castelao JE; Chang-Claude J; Chanock SJ; Cheng TD; Clarke CL; ; Colonna SV; Couch FJ; Cox A; Cross SS; Czene K; Daly MB; Dennis J; Dörk T; Dossus L; Dunning AM; Dwek M; Eccles DM; Ekici AB; Eliassen AH; Eriksson M; Evans DG; Fasching PA; Flyger H; Fritschi L; Gago-Dominguez M; García-Sáenz JA; Giles GG; Grip M; Guénel P; Gündert M; Hahnen E; Haiman CA; Håkansson N; Hall P; Hamann U; Hart SN; Hartikainen JM; Hartmann A; He W; Hooning MJ; Hoppe R; Hopper JL; Howell A; Hunter DJ; ; ; Jager A; Jakubowska A; Janni W; John EM; Jung AY; Kaaks R; Keupers M; Kitahara CM; Koutros S; Kraft P; Kristensen VN; Kurian AW; Lacey JV; Lambrechts D; Le Marchand L; Lindblom A; Linet M; Luben RN; Lubiński J; Lush M; Mannermaa A; Manoochehri M; Margolin S; Martens JWM; Martinez ME; Mavroudis D; Michailidou K; Milne RL; Mulligan AM; Muranen TA; Nevanlinna H; Newman WG; Nielsen SF; Nordestgaard BG; Olshan AF; Olsson H; Orr N; Park-Simon TW; Patel AV; Peissel B; Peterlongo P; Plaseska-Karanfilska D; Prajzendanc K; Prentice R; Presneau N; Rack B; Rennert G; Rennert HS; Rhenius V; Romero A; Roylance R; Ruebner M; Saloustros E; Sawyer EJ; Schmutzler RK; Schneeweiss A; Scott C; Shah M; Smichkoska S; Southey MC; Stone J; Surowy H; Swerdlow AJ; Tamimi RM; Tapper WJ; Teras LR; Terry MB; Tollenaar RAEM; Tomlinson I; Troester MA; Truong T; Vachon CM; Wang Q; Hurson AN; Winqvist R; Wolk A; Ziogas A; Brauch H; García-Closas M; Pharoah PDP; Easton DF; Chenevix-Trench G; Schmidt MK
Breast Cancer Res; 2021 Aug; 23(1):86. PubMed ID: 34407845
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel genetic markers of breast cancer survival.
Guo Q; Schmidt MK; Kraft P; Canisius S; Chen C; Khan S; Tyrer J; Bolla MK; Wang Q; Dennis J; Michailidou K; Lush M; Kar S; Beesley J; Dunning AM; Shah M; Czene K; Darabi H; Eriksson M; Lambrechts D; Weltens C; Leunen K; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Blomqvist C; Aittomäki K; Fagerholm R; Muranen TA; Couch FJ; Olson JE; Vachon C; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Broeks A; Hogervorst FB; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Hopper JL; Tsimiklis H; Apicella C; Southey MC; Cox A; Cross SS; Reed MW; Giles GG; Milne RL; McLean C; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Hooning MJ; Hollestelle A; Martens JW; van den Ouweland AM; Marme F; Schneeweiss A; Yang R; Burwinkel B; Figueroa J; Chanock SJ; Lissowska J; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Brenner H; Dieffenbach AK; Arndt V; Holleczek B; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Li J; Brand JS; Humphreys K; Devilee P; Tollenaar RA; Seynaeve C; Radice P; Peterlongo P; Bonanni B; Mariani P; Fasching PA; Beckmann MW; Hein A; Ekici AB; Chenevix-Trench G; Balleine R; ; Phillips KA; Benitez J; Zamora MP; Arias Perez JI; Menéndez P; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Hamann U; Kabisch M; Ulmer HU; Rüdiger T; Margolin S; Kristensen V; Nord S; Evans DG; Abraham JE; Earl HM; Hiller L; Dunn JA; Bowden S; Berg C; Campa D; Diver WR; Gapstur SM; Gaudet MM; Hankinson SE; Hoover RN; Hüsing A; Kaaks R; Machiela MJ; Willett W; Barrdahl M; Canzian F; Chin SF; Caldas C; Hunter DJ; Lindstrom S; García-Closas M; Hall P; Easton DF; Eccles DM; Rahman N; Nevanlinna H; Pharoah PD
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25890600
[TBL] [Abstract][Full Text] [Related]
4. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.
Lei J; Rudolph A; Moysich KB; Rafiq S; Behrens S; Goode EL; Pharoah PP; Seibold P; Fasching PA; Andrulis IL; Kristensen VN; Couch FJ; Hamann U; Hooning MJ; Nevanlinna H; Eilber U; Bolla MK; Dennis J; Wang Q; Lindblom A; Mannermaa A; Lambrechts D; García-Closas M; Hall P; Chenevix-Trench G; Shah M; Luben R; Haeberle L; Ekici AB; Beckmann MW; Knight JA; Glendon G; Tchatchou S; Alnæs GI; Borresen-Dale AL; Nord S; Olson JE; Hallberg E; Vachon C; Torres D; Ulmer HU; Rüdiger T; Jager A; van Deurzen CH; Tilanus-Linthorst MM; Muranen TA; Aittomäki K; Blomqvist C; Margolin S; Kosma VM; Hartikainen JM; Kataja V; Hatse S; Wildiers H; Smeets A; Figueroa J; Chanock SJ; Lissowska J; Li J; Humphreys K; Phillips KA; ; Linn S; Cornelissen S; van den Broek SA; Kang D; Choi JY; Park SK; Yoo KY; Hsiung CN; Wu PE; Hou MF; Shen CY; Teo SH; Taib NA; Yip CH; Ho GF; Matsuo K; Ito H; Iwata H; Tajima K; Dunning AM; Benitez J; Czene K; Sucheston LE; Maishman T; Tapper WJ; Eccles D; Easton DF; Schmidt MK; Chang-Claude J
Breast Cancer Res; 2015 Feb; 17(1):18. PubMed ID: 25849327
[TBL] [Abstract][Full Text] [Related]
5. Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival.
Azzato EM; Tyrer J; Fasching PA; Beckmann MW; Ekici AB; Schulz-Wendtland R; Bojesen SE; Nordestgaard BG; Flyger H; Milne RL; Arias JI; Menéndez P; Benítez J; Chang-Claude J; Hein R; Wang-Gohrke S; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Margolin S; Mannermaa A; Kosma VM; Kataja V; ; Beesley J; Chen X; Chenevix-Trench G; Couch FJ; Olson JE; Fredericksen ZS; Wang X; Giles GG; Severi G; Baglietto L; Southey MC; Devilee P; Tollenaar RA; Seynaeve C; García-Closas M; Lissowska J; Sherman ME; Bolton KL; Hall P; Czene K; Cox A; Brock IW; Elliott GC; Reed MW; Greenberg D; Anton-Culver H; Ziogas A; Humphreys M; Easton DF; Caporaso NE; Pharoah PD
J Natl Cancer Inst; 2010 May; 102(9):650-62. PubMed ID: 20308648
[TBL] [Abstract][Full Text] [Related]
6. Quantitative measures of estrogen receptor expression in relation to breast cancer-specific mortality risk among white women and black women.
Ma H; Lu Y; Marchbanks PA; Folger SG; Strom BL; McDonald JA; Simon MS; Weiss LK; Malone KE; Burkman RT; Sullivan-Halley J; Deapen DM; Press MF; Bernstein L
Breast Cancer Res; 2013; 15(5):R90. PubMed ID: 24070170
[TBL] [Abstract][Full Text] [Related]
7. Single nucleotide variants in metastasis-related genes are associated with breast cancer risk, by lymph node involvement and estrogen receptor status, in women with European and African ancestry.
Roberts MR; Sucheston-Campbell LE; Zirpoli GR; Higgins M; Freudenheim JL; Bandera EV; Ambrosone CB; Yao S
Mol Carcinog; 2017 Mar; 56(3):1000-1009. PubMed ID: 27597141
[TBL] [Abstract][Full Text] [Related]
8. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L
BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215
[TBL] [Abstract][Full Text] [Related]
9. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer.
Haiman CA; Chen GK; Vachon CM; Canzian F; Dunning A; Millikan RC; Wang X; Ademuyiwa F; Ahmed S; Ambrosone CB; Baglietto L; Balleine R; Bandera EV; Beckmann MW; Berg CD; Bernstein L; Blomqvist C; Blot WJ; Brauch H; Buring JE; Carey LA; Carpenter JE; Chang-Claude J; Chanock SJ; Chasman DI; Clarke CL; Cox A; Cross SS; Deming SL; Diasio RB; Dimopoulos AM; Driver WR; Dünnebier T; Durcan L; Eccles D; Edlund CK; Ekici AB; Fasching PA; Feigelson HS; Flesch-Janys D; Fostira F; Försti A; Fountzilas G; Gerty SM; ; Giles GG; Godwin AK; Goodfellow P; Graham N; Greco D; Hamann U; Hankinson SE; Hartmann A; Hein R; Heinz J; Holbrook A; Hoover RN; Hu JJ; Hunter DJ; Ingles SA; Irwanto A; Ivanovich J; John EM; Johnson N; Jukkola-Vuorinen A; Kaaks R; Ko YD; Kolonel LN; Konstantopoulou I; Kosma VM; Kulkarni S; Lambrechts D; Lee AM; Marchand LL; Lesnick T; Liu J; Lindstrom S; Mannermaa A; Margolin S; Martin NG; Miron P; Montgomery GW; Nevanlinna H; Nickels S; Nyante S; Olswold C; Palmer J; Pathak H; Pectasides D; Perou CM; Peto J; Pharoah PD; Pooler LC; Press MF; Pylkäs K; Rebbeck TR; Rodriguez-Gil JL; Rosenberg L; Ross E; Rüdiger T; Silva Idos S; Sawyer E; Schmidt MK; Schulz-Wendtland R; Schumacher F; Severi G; Sheng X; Signorello LB; Sinn HP; Stevens KN; Southey MC; Tapper WJ; Tomlinson I; Hogervorst FB; Wauters E; Weaver J; Wildiers H; Winqvist R; Van Den Berg D; Wan P; Xia LY; Yannoukakos D; Zheng W; Ziegler RG; Siddiq A; Slager SL; Stram DO; Easton D; Kraft P; Henderson BE; Couch FJ
Nat Genet; 2011 Oct; 43(12):1210-4. PubMed ID: 22037553
[TBL] [Abstract][Full Text] [Related]
10. High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.
Riaz M; Sieuwerts AM; Look MP; Timmermans MA; Smid M; Foekens JA; Martens JW
Breast Cancer Res; 2012 Sep; 14(5):R123. PubMed ID: 22967435
[TBL] [Abstract][Full Text] [Related]
11. Body mass index and breast cancer survival: a Mendelian randomization analysis.
Guo Q; Burgess S; Turman C; Bolla MK; Wang Q; Lush M; Abraham J; Aittomäki K; Andrulis IL; Apicella C; Arndt V; Barrdahl M; Benitez J; Berg CD; Blomqvist C; Bojesen SE; Bonanni B; Brand JS; Brenner H; Broeks A; Burwinkel B; Caldas C; Campa D; Canzian F; Chang-Claude J; Chanock SJ; Chin SF; Couch FJ; Cox A; Cross SS; Cybulski C; Czene K; Darabi H; Devilee P; Diver WR; Dunning AM; Earl HM; Eccles DM; Ekici AB; Eriksson M; Evans DG; Fasching PA; Figueroa J; Flesch-Janys D; Flyger H; Gapstur SM; Gaudet MM; Giles GG; Glendon G; Grip M; Gronwald J; Haeberle L; Haiman CA; Hall P; Hamann U; Hankinson S; Hartikainen JM; Hein A; Hiller L; Hogervorst FB; Holleczek B; Hooning MJ; Hoover RN; Humphreys K; Hunter DJ; Hüsing A; Jakubowska A; Jukkola-Vuorinen A; Kaaks R; Kabisch M; Kataja V; ; Knight JA; Koppert LB; Kosma VM; Kristensen VN; Lambrechts D; Le Marchand L; Li J; Lindblom A; Lindström S; Lissowska J; Lubinski J; Machiela MJ; Mannermaa A; Manoukian S; Margolin S; Marme F; Martens JWM; McLean C; Menéndez P; Milne RL; Marie Mulligan A; Muranen TA; Nevanlinna H; Neven P; Nielsen SF; Nordestgaard BG; Olson JE; Perez JIA; Peterlongo P; Phillips KA; Poole CJ; Pylkäs K; Radice P; Rahman N; Rüdiger T; Rudolph A; Sawyer EJ; Schumacher F; Seibold P; Seynaeve C; Shah M; Smeets A; Southey MC; Tollenaar RAEM; Tomlinson I; Tsimiklis H; Ulmer HU; Vachon C; van den Ouweland AMW; Van't Veer LJ; Wildiers H; Willett W; Winqvist R; Zamora MP; Chenevix-Trench G; Dörk T; Easton DF; García-Closas M; Kraft P; Hopper JL; Zheng W; Schmidt MK; Pharoah PDP
Int J Epidemiol; 2017 Dec; 46(6):1814-1822. PubMed ID: 29232439
[TBL] [Abstract][Full Text] [Related]
12. An investigation of the association of genetic susceptibility risk with somatic mutation burden in breast cancer.
Zhu B; Mukherjee A; Machiela MJ; Song L; Hua X; Shi J; Garcia-Closas M; Chanock SJ; Chatterjee N
Br J Cancer; 2016 Sep; 115(6):752-60. PubMed ID: 27467053
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.
Huo D; Hu H; Rhie SK; Gamazon ER; Cherniack AD; Liu J; Yoshimatsu TF; Pitt JJ; Hoadley KA; Troester M; Ru Y; Lichtenberg T; Sturtz LA; Shelley CS; Benz CC; Mills GB; Laird PW; Shriver CD; Perou CM; Olopade OI
JAMA Oncol; 2017 Dec; 3(12):1654-1662. PubMed ID: 28472234
[TBL] [Abstract][Full Text] [Related]
14. Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer.
Dignam JJ; Wieand K; Johnson KA; Raich P; Anderson SJ; Somkin C; Wickerham DL
Breast Cancer Res Treat; 2006 Jun; 97(3):245-54. PubMed ID: 16331345
[TBL] [Abstract][Full Text] [Related]
15. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
Couch FJ; Gaudet MM; Antoniou AC; Ramus SJ; Kuchenbaecker KB; Soucy P; Beesley J; Chen X; Wang X; Kirchhoff T; McGuffog L; Barrowdale D; Lee A; Healey S; Sinilnikova OM; Andrulis IL; ; Ozcelik H; Mulligan AM; Thomassen M; Gerdes AM; Jensen UB; Skytte AB; Kruse TA; Caligo MA; von Wachenfeldt A; Barbany-Bustinza G; Loman N; Soller M; Ehrencrona H; Karlsson P; ; Nathanson KL; Rebbeck TR; Domchek SM; Jakubowska A; Lubinski J; Jaworska K; Durda K; Zlowocka E; Huzarski T; Byrski T; Gronwald J; Cybulski C; Górski B; Osorio A; Durán M; Tejada MI; Benitez J; Hamann U; Hogervorst FB; ; van Os TA; van Leeuwen FE; Meijers-Heijboer HE; Wijnen J; Blok MJ; Kets M; Hooning MJ; Oldenburg RA; Ausems MG; Peock S; Frost D; Ellis SD; Platte R; Fineberg E; Evans DG; Jacobs C; Eeles RA; Adlard J; Davidson R; Eccles DM; Cole T; Cook J; Paterson J; Brewer C; Douglas F; Hodgson SV; Morrison PJ; Walker L; Porteous ME; Kennedy MJ; Side LE; ; Bove B; Godwin AK; Stoppa-Lyonnet D; ; Fassy-Colcombet M; Castera L; Cornelis F; Mazoyer S; Léoné M; Boutry-Kryza N; Bressac-de Paillerets B; Caron O; Pujol P; Coupier I; Delnatte C; Akloul L; Lynch HT; Snyder CL; Buys SS; Daly MB; Terry M; Chung WK; John EM; Miron A; Southey MC; Hopper JL; Goldgar DE; Singer CF; Rappaport C; Tea MK; Fink-Retter A; Hansen TV; Nielsen FC; Arason A; Vijai J; Shah S; Sarrel K; Robson ME; Piedmonte M; Phillips K; Basil J; Rubinstein WS; Boggess J; Wakeley K; Ewart-Toland A; Montagna M; Agata S; Imyanitov EN; Isaacs C; Janavicius R; Lazaro C; Blanco I; Feliubadalo L; Brunet J; Gayther SA; Pharoah PP; Odunsi KO; Karlan BY; Walsh CS; Olah E; Teo SH; Ganz PA; Beattie MS; van Rensburg EJ; Dorfling CM; Diez O; Kwong A; Schmutzler RK; Wappenschmidt B; Engel C; Meindl A; Ditsch N; Arnold N; Heidemann S; Niederacher D; Preisler-Adams S; Gadzicki D; Varon-Mateeva R; Deissler H; Gehrig A; Sutter C; Kast K; Fiebig B; Heinritz W; Caldes T; de la Hoya M; Muranen TA; Nevanlinna H; Tischkowitz MD; Spurdle AB; Neuhausen SL; Ding YC; Lindor NM; Fredericksen Z; Pankratz VS; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Barile M; Bernard L; Viel A; Giannini G; Varesco L; Radice P; Greene MH; Mai PL; Easton DF; Chenevix-Trench G; ; Offit K; Simard J;
Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):645-57. PubMed ID: 22351618
[TBL] [Abstract][Full Text] [Related]
16. A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry.
Middha P; Wang X; Behrens S; Bolla MK; Wang Q; Dennis J; Michailidou K; Ahearn TU; Andrulis IL; Anton-Culver H; Arndt V; Aronson KJ; Auer PL; Augustinsson A; Baert T; Freeman LEB; Becher H; Beckmann MW; Benitez J; Bojesen SE; Brauch H; Brenner H; Brooks-Wilson A; Campa D; Canzian F; Carracedo A; Castelao JE; Chanock SJ; Chenevix-Trench G; ; Cordina-Duverger E; Couch FJ; Cox A; Cross SS; Czene K; Dossus L; Dugué PA; Eliassen AH; Eriksson M; Evans DG; Fasching PA; Figueroa JD; Fletcher O; Flyger H; Gabrielson M; Gago-Dominguez M; Giles GG; González-Neira A; Grassmann F; Grundy A; Guénel P; Haiman CA; Håkansson N; Hall P; Hamann U; Hankinson SE; Harkness EF; Holleczek B; Hoppe R; Hopper JL; Houlston RS; Howell A; Hunter DJ; Ingvar C; ; ; Isaksson K; Jernström H; John EM; Jones ME; Kaaks R; Keeman R; Kitahara CM; Ko YD; Koutros S; Kurian AW; Lacey JV; Lambrechts D; Larson NL; Larsson S; Le Marchand L; Lejbkowicz F; Li S; Linet M; Lissowska J; Martinez ME; Maurer T; Mulligan AM; Mulot C; Murphy RA; Newman WG; Nielsen SF; Nordestgaard BG; Norman A; O'Brien KM; Olson JE; Patel AV; Prentice R; Rees-Punia E; Rennert G; Rhenius V; Ruddy KJ; Sandler DP; Scott CG; Shah M; Shu XO; Smeets A; Southey MC; Stone J; Tamimi RM; Taylor JA; Teras LR; Tomczyk K; Troester MA; Truong T; Vachon CM; Wang SS; Weinberg CR; Wildiers H; Willett W; Winham SJ; Wolk A; Yang XR; Zamora MP; Zheng W; Ziogas A; Dunning AM; Pharoah PDP; García-Closas M; Schmidt MK; Kraft P; Milne RL; Lindström S; Easton DF; Chang-Claude J
Breast Cancer Res; 2023 Aug; 25(1):93. PubMed ID: 37559094
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer.
Huo D; Feng Y; Haddad S; Zheng Y; Yao S; Han YJ; Ogundiran TO; Adebamowo C; Ojengbede O; Falusi AG; Zheng W; Blot W; Cai Q; Signorello L; John EM; Bernstein L; Hu JJ; Ziegler RG; Nyante S; Bandera EV; Ingles SA; Press MF; Deming SL; Rodriguez-Gil JL; Nathanson KL; Domchek SM; Rebbeck TR; Ruiz-Narváez EA; Sucheston-Campbell LE; Bensen JT; Simon MS; Hennis A; Nemesure B; Leske MC; Ambs S; Chen LS; Qian F; Gamazon ER; Lunetta KL; Cox NJ; Chanock SJ; Kolonel LN; Olshan AF; Ambrosone CB; Olopade OI; Palmer JR; Haiman CA
Hum Mol Genet; 2016 Nov; 25(21):4835-4846. PubMed ID: 28171663
[TBL] [Abstract][Full Text] [Related]
18. Novel genetic markers of breast cancer survival identified by a genome-wide association study.
Shu XO; Long J; Lu W; Li C; Chen WY; Delahanty R; Cheng J; Cai H; Zheng Y; Shi J; Gu K; Wang WJ; Kraft P; Gao YT; Cai Q; Zheng W
Cancer Res; 2012 Mar; 72(5):1182-9. PubMed ID: 22232737
[TBL] [Abstract][Full Text] [Related]
19. Associations between genetic variants in the TGF-β signaling pathway and breast cancer risk among Hispanic and non-Hispanic white women.
Boone SD; Baumgartner KB; Baumgartner RN; Connor AE; Pinkston CM; John EM; Hines LM; Stern MC; Giuliano AR; Torres-Mejia G; Brock GN; Groves FD; Kerber RA; Wolff RK; Slattery ML
Breast Cancer Res Treat; 2013 Sep; 141(2):287-97. PubMed ID: 24036662
[TBL] [Abstract][Full Text] [Related]
20. Variants of estrogen-related genes and breast cancer risk in European and African American women.
Quan L; Hong CC; Zirpoli G; Roberts MR; Khoury T; Sucheston-Campbell LE; Bovbjerg DH; Jandorf L; Pawlish K; Ciupak G; Davis W; Bandera EV; Ambrosone CB; Yao S
Endocr Relat Cancer; 2014; 21(6):853-64. PubMed ID: 25228414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
